Danny Hart
2013
In 2013, Danny Hart earned a total compensation of $953.3K as Vice President, Business Development at PDL BioPharma, a 90% increase compared to previous year.
Compensation breakdown
| Bonus | $222,710 |
|---|---|
| Non-Equity Incentive Plan | $306,310 |
| Salary | $286,888 |
| Stock Awards | $97,390 |
| Other | $40,000 |
| Total | $953,298 |
Hart received $306.3K in non-equity incentive plan, accounting for 32% of the total pay in 2013.
Hart also received $222.7K in bonus, $286.9K in salary, $97.4K in stock awards and $40K in other compensation.
Rankings
In 2013, Danny Hart's compensation ranked 6,853rd out of 12,286 executives tracked by ExecPay. In other words, Hart earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,853 out of 12,286 | 44th |
Division Manufacturing | 2,432 out of 4,612 | 47th |
Major group Chemicals And Allied Products | 738 out of 1,466 | 50th |
Industry group Drugs | 545 out of 1,160 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 89 out of 200 | 56th |
Source: SEC filing on April 20, 2016.
Hart's colleagues
We found five more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2013.
2013
John McLaughlin
PDL BioPharma
Chief Executive Officer
2013
Christopher Stone
PDL BioPharma
General Counsel
2013
Peter Garcia
PDL BioPharma
Chief Financial Officer
2013
David Montez
PDL BioPharma
Chief Accounting Officer
2013
Caroline Krumel
PDL BioPharma